Billionaire Paulson Boosts Mylan Holding Amid Teva Battle

Updated on

John Paulson’s hedge fund boosted its stake in Mylan NV to 4.5 percent, signaling that the billionaire may want a bigger say in the fate of the drugmaker as it fends off Teva Pharmaceutical Industries Ltd.’s unsolicited takeover bid.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.